Breast Neoplasms - Blood
Research News and Information

Sunday, November 22, 2009

Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.

29 Nov 2009 Experimental and epidemiological evidence suggests that circulating glucose and insulin may play a role in breast carcinogenesis. However, few cohort studies have examined breast cancer risk in association with glucose and insulin levels, and ... Read more...

Elevated level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls.

30 Oct 2009 Carriers of BRCA1 mutation face highly increased risk of breast and ovarian cancer and some studies with cell culture suggest that the encoded protein may be involved in oxidatively damaged DNA repair. However, no studies concerning a possible link ... Read more...

Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk.

7 Oct 2009 BACKGROUND: Müllerian inhibiting substance (MIS) is a member of the transforming growth factor beta family of growth and differentiation factors that inhibits elongation and branching of mammary ducts and has been shown to inhibit mammary tumor ... Read more...

Latest indexed articles for 'Breast Neoplasms - Blood'

These are the very latest articles for this heading:

• Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. 29 Nov 2009
• Elevated level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls. 30 Oct 2009
• Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. 7 Oct 2009
• [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status] 29 Sep 2009
• Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. 12 Sep 2009
• Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays. 31 Aug 2009
• Circulating estrogen metabolites and risk for breast cancer in premenopausal women. 30 Jul 2009
• Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. 30 Jul 2009
• DNA oxidation and antioxidant status in breast cancer. 30 Jul 2009
• Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration. 30 Jul 2009
• Circulating and disseminated tumor cells in the management of breast cancer. 30 Jul 2009
• Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. 19 Jul 2009
• Caution regarding 25-hydroxyvitamin D monitoring in women with breast cancer. 18 Jul 2009
• Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. 11 Jul 2009
• Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. 11 Jul 2009
• Surrogate response biomarkers in prevention research: do they point the way or lead us astray? 11 Jul 2009
• Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status. 6 Jul 2009
• Quantitation of amino acids in plasma by high performance liquid chromatography: simultaneous deproteinization and derivatization with 9-fluorenylmethyloxycarbonyl chloride. 5 Jul 2009
• Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. 5 Jul 2009
• Premenopausal breast cancer: estrogen receptor status and insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3), and leptin. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Breast Neoplasms'

Definition: Tumors or cancer of the human BREAST.

Descriptor UI: D001943

Alternative terms: Breast Neoplasms; Breast Neoplasm; Neoplasm, Breast; Neoplasms, Breast; Tumors, Breast; Breast Tumors; Breast Tumor; Tumor, Breast; Mammary Carcinoma, Human; Carcinoma, Human Mammary; Carcinomas, Human Mammary; Human Mammary Carcinomas; Mammary Carcinomas, Human; Human Mammary Carcinoma; Mammary Neoplasms, Human; Human Mammary Neoplasm; Human Mammary Neoplasms; Neoplasm, Human Mammary; Neoplasms, Human Mammary; Mammary Neoplasm, Human; Breast Cancer; Cancer, Breast; Cancer of the Breast; Cancer of Breast;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.180; C17.800.090.500;

Technical Notes: human only; BREAST NEOPLASMS, MALE is also available; for animal use MAMMARY NEOPLASMS, ANIMAL or MAMMARY NEOPLASMS, EXPERIMENTAL: Manual 24.5+, 24.6+; coordinate IM with histological type of neoplasm (IM)